Showing results (591-600 of 5,340) with videos related to
Sort By:
Pageof 534
Japanese Journal of Clinical Oncology|February 9, 2008
Possible impact of the NHK special questioning cancer treatment in Japan on clinicians' prescriptions of oxaliplatinTomoko Matsumura, Koichiro Yuji, Toshihito Nakamura, et al.Japanese Journal of Clinical Oncology|February 15, 2008
DNA repair gene hOGG1 codon 326 and XRCC1 codon 399 polymorphisms and bladder cancer risk in a Japanese populationKatsuyuki Arizono, Yukio Osada, Yoshiki KurodaJapanese Journal of Clinical Oncology|February 15, 2008
Height, urban-born and prostate cancer risk in Japanese menYuko Minami, Tatsuo Tochigi, Sadafumi Kawamura, et al.Japanese Journal of Clinical Oncology|February 15, 2008
Randomized phase III trial of adjuvant chemotherapy with gemcitabine versus S-1 in patients with resected pancreatic cancer: Japan Adjuvant Study Group of Pancreatic Cancer (JASPAC-01)Atsuyuki Maeda, Narikazu Boku, Akira Fukutomi, et al.Japanese Journal of Clinical Oncology|April 25, 2008
Efficacy and safety of pemetrexed in combination with cisplatin for malignant pleural mesothelioma: a phase I/II study in Japanese patientsKazuhiko Nakagawa, Koichi Yamazaki, Hideo Kunitoh, et al.Japanese Journal of Clinical Oncology|January 8, 1999
Expression of alpha-fetoprotein and prostate-specific antigen genes in several tissues and detection of mRNAs in normal circulating blood by reverse transcriptase-polymerase chain reactionT Ishikawa, H Kashiwagi, Y Iwakami, et al.Japanese Journal of Clinical Oncology|January 8, 1999
Quality of life (QOL) assessment of MIP (mitomycin, ifosfamide and cisplatin) chemotherapy in advanced non-small cell lung cancers (NSCLC)J Y Han, H K Kim, B G Choi, et al.Japanese Journal of Clinical Oncology|January 8, 1999
Dedifferentiated chordoma: a case reportA Saito, T Hasegawa, T Shimoda, et al.Japanese Journal of Clinical Oncology|January 27, 2006
Feasibility of imprint cytology for evaluation of mediastinal lymph nodes in lung cancerAlpay Orki, Cagatay Tezel, Altug Kosar, et al.Japanese Journal of Clinical Oncology|January 27, 2006
Intermediate dose 5-fluorouracil-induced encephalopathyYeon-A Kim, Hyun Cheol Chung, Hye Jin Choi, et al.Pageof 534